Treating depression in Alzheimer disease: Efficacy and safety of sertraline therapy, and the benefits of depression reduction: The DIADS

Archives of General Psychiatry

Volumn 60, Issue 7, 2003, Pages 737-746

  Lyketsos, Constantine G ^a,c,d   DelCampo, Lourdes ^a   Steinberg, Martin ^a,c   Miles, Quincy ^a   Steele, Cynthia D ^a,c   Munro, Cynthia ^a   Baker, Alva S ^a,c   Sheppard, Jeannie Marie E ^a,b   Frangakis, Constantine ^b   Brandt, Jason ^a,c   Rabins, Peter V ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c The Copper Ridge Institute   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SERTRALINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BEHAVIOR DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MEDICAL ASSESSMENT; MINI MENTAL STATE EXAMINATION; OUTPATIENT; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REDUCTION; SINGLE BLIND PROCEDURE;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; AMBULATORY CARE; CAREGIVERS; COGNITION DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; DRUG ADMINISTRATION SCHEDULE; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; MENTAL DISORDERS; NEUROPSYCHOLOGICAL TESTS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SINGLE-BLIND METHOD; TREATMENT OUTCOME;

EID: 0038016529     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.60.7.737     Document Type: Article

References (65)

1. Mega MS, Cummings JL, Fiorello T, Gornbein J. The spectrum of behavioral changes in Alzheimer's disease. Neurology. 1996;46:130-135.
2. Finkel S. Behavioral disturbance in dementia. Int Psychogeriatr. 1996;8(suppl 3):215-551.
3. Drevets WC, Rubin EH. Psychotic symptoms and the longitudinal course of Alzheimer disease. Biol Psychiatry. 1989;25:39-48.
4. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer disease, I: disorders of thought content. Br J Psychiatry. 1990;157:72-76.
5. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer disease, II: disorders of perception. Br J Psychiatry. 1990;157:76-81.
6. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer disease, III: disorders of mood. Br J Psychiatry. 1990;157:81-86.
7. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer disease, IV: disorders of behavior. Br J Psychiatry. 1990;157:86-94.
8. Lyketsos CG, Steinberg M, Tschantz J, Norton M, Steffens D, Breitner JC. Mental and behavioral disturbances in dementia: findings from the Cache County study on memory in aging. Am J Psychiatry. 2000;157:708-714.
9. American Psychiatric Association. Practice guideline for the treatment of dementia and Alzheimer's disease. Am J Psychiatry. 1997;154(suppl 5):1-39.
10. Doody RS, Stevens JC, Beck C, Dubinsky RM, Kaye JA, Gwyther L, Mohs RC, Thal LJ, Whitehouse PJ, DeKosky ST, Cummings JL. Practice parameter: management of dementia (an evidence based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56:1154-1166.
11. Lyketsos CG, Olin JT. Depression in Alzheimer's disease: overview and treatment. Biol Psychiatry. 2002;52:243-252.
12. Olin JT, Schneider LS, Katz IR, Meyers BS, Alexopoulos GS, Breitner JC, Bruce ML, Caine ED, Cummings JL, Devanand DP, Krishnan KR, Lyketsos CG, Lyness JM, Rabin PV, Reynolds CF III, Rovner BW, Steffens DC, Tariot PN, Lebowitz BD. National Institute of Mental Health-Provisional Diagnostic Criteria for Depression of Alzheimer Disease: rationale and background. Am J Geriatr Psychiatry. 2002;10:125-128.
13. Ballard C, Bannister C, Solis M, Oyebode F, Wilcock G. The prevalence, association and symptoms of depression amongst dementia sufferers. J Affect Disord. 1996;36:136-144.
14. Payne J, Sheppard JE, Steinberg M, Warren A, Baker A, Steele C, Brandt J, Lyketsos CG. Incidence, prevalence, and outcomes of depression in residents of a long-term care facility with dementia. Int J Geriatr Psychiatry. 2002;17:247-253.
15. Parmelee PA, Katz IR, Lawton MP. Depression among institutionalized aged: assessment and prevalence estimation. J Gerontol. 1989;44:M22-M29.
16. Devanand DP, Jacobs DM, Tang MX, Castillo-Casteneda C, Sano M, Marder K, Bell K, Bylsma FW, Brandt J, Albert M, Stern Y. The course of psychopathologic features in mild to moderate Alzheimer's disease. Arch Gen Psychiatry. 1997; 54:257-263.
17. Gonzales-Salvador T, Lyketsos CG, Baker AS, Roques C, Hovanek L, Steele CD, Brandt J. Quality of life of patients with dementia in long-term care. Int J Geriatr Psychiatry. 2000;15:181-189.
18. Lyketsos CG, Baker L, Warren A, Steele C, Brandt J, Steinberg M, Kopunek S, Baker A. Major and minor depression in Alzheimer's disease: prevalence and impact. J Neuropsychiatry Clin Neurosci. 1997;9:556-561.
19. Lyketsos CG, Steele C, Galik E, Rosenblatt A, Steinberg M, Warren A, Sheppard JM. Physical aggression in dementia patients and its relationship to depression. Am J Psychiatry. 1999;156:66-71.
20. Kopetz ES, Steele CD, Brandt J, Baker AS, Kronberg M, Galik E, Steinberg M, Warren A, Lyketsos CG. Characteristics and outcomes of dementia residents in an assisted living facility. Int J Geriatr Psychiatry. 2000;15:586-593.
21. Steele C, Rovner B, Chase GA, Folstein M. Psychiatric symptoms and nursing home placement of patients with Alzheimer's disease. Am J Psychiatry. 1990; 147:1049-1051.
22. Gonzales-Salvador T, Aragano C, Lyketsos CG, Barba AC. The stress and psychological morbidity of the Alzheimer patient caregiver. Int J Geriatr Psychiatry. 1999;14:701-710.
23. Hoch CC, Reynolds CF, Buysse DJ. Two-year survival in patients with mixed symptoms of depression and cognitive impairment: comparison with major depression and primary degenerative dementia. Am J Geriatr Psychiatry. 1993;1:59-66.
24. Rubio A, Vestner AL, Stewart JM, Forbes NT, Conwell Y, Cox C. Suicide and Alzheimer's pathology in the elderly: a case-control study. Biol Psychiatry. 2001; 49:137-145.
25. DeBettignies BH, Mahurin RK, Pirozzolo FJ. Insight for impairment in independent living skills in Alzheimer's disease and multi-infarct dementia. J Clin Exp Neuropsychol. 1990;12:355-363
26. Verhey FRJ, Rozendaal N, Ponds RWHM, Jolles J. Dementia, awareness, and depression. Int J Geriatr Psychiatry. 1993;8:851-856.
27. Ballard CG, Cassidy G, Bannister C, Mohan RN. Prevalence, symptom profile, and aetiology of depression in dementia sufferers. J Affect Disord. 1993;19:1-6.
28. Migliorelli R, Tesona Sabe L, Petracchi M, Leiguarda R, Starkstein SE. Prevalence and correlates of dysthymia and major depression among patients with Alzheimer's disease. Am J Psychiatry. 1995;152:37-44.
29. Cummings JL, Ross W, Absher J, Gornbein J, Hadjiaghai L. Depressive symptoms in Alzheimer's disease: assessments and determinants. Alzheimer Dis Assoc Disord. 1995;9:87-93.
30. Ott BR, Lafleche G, Whelihan WM, Buongiorno GW, Albert MS, Fogel BS. Impaired awareness of deficits in Alzheimer's disease. Alzheimer Dis Assoc Disord. 1996;10:68-76.
31. Arkin S, Mahendra N. Insight in Alzheimer's patients: results of a longitudinal study using three assessment methods. Am J Alzheimers Dis Other Demen. 2001;16:211-224.
32. Payne JL, Lyketsos CG, Baker L, Warren A, Steele C, Brandt J, Steinberg M, Kopunek S, Baker A. The relationship of cognitive and functional impairment to depressive features in Alzheimer's disease and other dementias. J Neuropsychiatry Clin Neurosci. 1998;10:440-447.
33. Zweig RM, Ross CA, Hedreen JC. The neuropathology of aminergic nuclei in Alzheimer's disease. Ann Neurol. 1988;24:233-242.
34. Zweig RM, Ross CA, Hedreen JC, Steele C, Cardillo JE, Whitehouse PJ, Folstein MF, Price DL. Neuropathology of aminergic nuclei in Alzheimer disease. Prog Clin Biol Res. 1989;317:353-365.
35. Zubenko GS, Moossy J, Martinez AJ, Roa G, Claassen D, Rosen J, Kopp U. Neuropathologic and neurochemical correlates of psychosis in primary dementia. Arch Neurol. 1991;48:619-624.
36. Zubenko GS. Biological correlates of clinical heterogeneity in primary dementia. Neuropsychopharmacology. 1992;6:77-93.
37. Forstl H, Burns A, Luthert P. Clinical and neuropathological correlates of depression in Alzheimer's disease. Psychol Med. 1992;22:877-884.
38. Alexopoulos GS, Silver JM, Frances A, Carpenter D. Treatment of agitation in older persons with dementia. Postgrad Med Special Rep. April 1998:1-88.
39. Nyth AL, Gottfries CG, Lyby K, Smedegaard-Andersen L, Gylding-Sabroe J, Kristensen M, Refsum HE, Ofsti E, Eriksson S, Syversen S. A controlled multicenter clinical study of citalopram and placebo in elderly depressed patients with and without concomitant dementia. Acta Psychiatr Scand. 1992;86:138-145.
40. Petracca G, Teson A, Chemerinski E, Leiguarda R, Starkstein SE. A double-blind placebo controlled study of lomipramine in depressed patients with Alzheimer's disease. J Neuropsychiatry Clin Neurosci. 1996;8:227-275.
41. Roth M, Mountjoy CQ, Amrein R. Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial. Br J Psychiatry. 1996;168:149-157.
42. Reifler BV, Teri L, Raskind M, Veith R, Barnes R, White E, McLean P. Double-blind trial of imipramine in Alzheimer's disease patients with and without depression. Am J Psychiatry. 1989;146:45-49.
43. Nyth AL, Gottfries CG. The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders: a Nordic multicentre study. Br J Psychiatry. 1990;157:894-901.
44. Magai C, Kennedy G, Cohen CI, Gomberg D. A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease. Am J Geriatr Psychiatry. 2000;8:66-74.
45. Petracca GM, Chemerinski E, Starkstein SE. A double-blind placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease. Int Psychogeriatr. 2001;13:233-240.
46. Teri L, Logsdon RG, Uomoto J, McCurry SM. Behavioral treatment of depression in dementia patients: a controlled clinical trial. J Gerontol B Psychol Sci Soc Sci. 1997;52:P159-P166.
47. Rao V, Lyketsos CG. The benefits and risks of ECT for patients with degenerative dementia who also suffer from depression. Int J Geriatr Psychiatry. 2000;15: 729-735.
48. Lyketsos CG, Sheppard JME, Steele CS, Kopunek S, Steinberg M, Baker AS, Brandt J, Rabins PV. A randomized, placebo-controlled, double-blind, clinical trial of sertraline in the treatment of depression complicating Alzheimer disease: initial results from the Depression in Alzheimer Disease Study (DIADS). Am J Psychiatry. 2000;157:1686-1689.
49. McKhann G, Drachman D, Folstein MF, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-949.
50. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-198.
51. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994.
52. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960; 23:56-62.
53. Alexopoulos GS, Abrams RC, Young RC, Shamoian CA. Cornell Scale for Depression in Dementia. Biol Psychiatry. 1988;23:271-284.
54. Wilkinson IM, Graham-White J. Psychogeriatric Dependency Rating Scale: a method of assessment for use by nurses. Br J Psychiatry. 1980;137:558-565.
55. Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
56. Lyketsos CG, Chen LS, Anthony W. Cognitive decline in adulthood: an 11.5-year follow-up of the Baltimore Epidemiologic Catchment Area Study. Am J Psychiatry. 1999;156:58-65.
57. Inouye SK, van Dyck CH, Alessi CA, Balkin S, Siegal A, Horwitz R. Clarifying confusion: the confusion assessment method: a new method for detection of delirium. Ann Intern Med. 1990;113:941-948.
58. Lyketsos CG, Galik E, Steele C, Steinberg M, Rosenblatt A, Warren A, Sheppard JM, Baker A, Brandt J. The General Medical Health Rating: a bedside global rating of medical comorbidity in patients with dementia. J Am Geriatr Soc. 1999; 47:487-491.
59. Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M, and the Risperidone Study Group. Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. J Clin Psychiatry. 1999;60:107-115.
60. Street JS, Clark WS, Gannon KS, Cummings JL, Bymatser FP, Tamura RN, Mitan SJ, Kadam DL, Sanger TM, Feldman PD, Tollefson GD, Breier A, for the HGEU Study Group. Olanzapine in the treatment of psychotic and behavioral symptoms in patients with Alzheimer's disease in nursing care facilities. Arch Gen Psychiatry. 2000;57:968-976.
61. Tariot PN, Erb R, Podgorski CA, Cox C, Patel S, Jakimovich L, Irvine C. Efficacy and tolerability of carbamazepine for agitation and aggression in dementia. Am J Psychiatry. 1998;155:54-61.
62. Porsteinsson AP, Tariot PN, Erb R, Cox C, Smith E, Jakimovich L, Noviasky J, Kowalski N, Holt CJ, Irvine C. Placebo-controlled study of divalproex sodium for agitation in dementia. Am J Geriatr Psychiatry. 2001;9:58-66
63. Taragano FE, Lyketsos CG, Mangone CA, Allegri RF, Comesaña-Diaz E. Double-blind, randomized, fixed dose trial of fluoxetine versus amitriptyline in the treatment of major depression complicating Alzheimer's disease. Psychosomatics. 1997;38:246-252.
64. Katona CL, Hunter BN, Bray J. A double-blind comparison of the efficacy and safety of paroxetine and imipramine in the treatment of depression with dementia. Int J Geriatr Psychiatry. 1998;13:100-108.
65. Fuchs A, Hehnke U, Erhart C, Schell C, Pramshohler B, Danninger B, Schautzer F. Video rating analysis of effect of maprotiline in patients with dementia and depression. Pharmacopsychiatry. 1993;26:37-41.